How Insurers Choose Which Generics to Cover: The Real Rules Behind Formulary Decisions

How Insurers Choose Which Generics to Cover: The Real Rules Behind Formulary Decisions Nov, 16 2025

Every year, Americans fill over 4 billion prescriptions. More than 87% of those are for generic drugs. But here’s the question most people never ask: Why does your insurance cover one generic version of a drug but not another? It’s not random. It’s not arbitrary. It’s a cold, calculated system - and if you’ve ever been denied coverage for a generic, you’ve felt the weight of it.

It Starts with the P&T Committee

Behind every insurance formulary is a quiet group of experts called the Pharmacy & Therapeutics (P&T) committee. These aren’t marketing teams or accountants. They’re pharmacists, doctors, and health economists who meet monthly - sometimes weekly - to decide which drugs make the cut. Their job? Find the safest, most effective drugs that also cost the least.

The process isn’t secret, but it’s rarely transparent. Most insurers don’t publish their full decision logs. What we do know: every drug must first be approved by the FDA. That’s the baseline. After that, the P&T committee looks at three things: clinical effectiveness, safety, and cost.

A generic drug doesn’t need to be the cheapest to get covered. It needs to be the best value. Two generics might treat high blood pressure equally well. But if one costs $5 a month and the other costs $12, the $5 one wins. Every time.

Tiers Don’t Lie

Insurance plans don’t just say “yes” or “no.” They use tiers - a ranking system that tells you how much you pay at the pharmacy.

- Tier 1: Preferred generics. Usually $0-$15 for a 30-day supply. This is where 92% of Medicare Part D plans put their generics. These are the drugs insurers want you to use.

- Tier 2: Non-preferred generics or low-cost brand-name drugs. Might cost $40.

- Tier 3+: Specialty drugs, brand-name meds, or complex generics. Could cost $100 or more.

The structure is simple: lower tier = lower cost to you. Insurers push you toward Tier 1 because it saves them money - and they pass some of those savings to you in lower premiums.

Blue Shield of California, Humana, and UnitedHealthcare all use this model. So does Medicare. The only real difference? Some plans have five tiers. Others have three. But Tier 1 is always the same: low-cost generics.

Why Not All Generics Are Created Equal

Here’s the twist: two generics with the same active ingredient can still be treated differently.

The FDA says they’re therapeutically equivalent. But insurers don’t just look at the label. They look at real-world data. Did patients on Generic A have fewer side effects than Generic B? Did Generic C have more refill issues? Did a particular manufacturer have supply problems?

In 2023, the FDA reported 372 active drug shortages. Nearly 78% of them were generics. If a generic from Manufacturer X keeps running out, insurers will drop it - even if it’s cheap. They need reliability. A $3 drug that’s out of stock every other month isn’t a bargain. It’s a headache.

That’s why big manufacturers like Teva, Sandoz, and Mylan dominate formularies. They have the scale, the track record, and the supply chains to deliver consistently.

A pharmacist giving a patient a different generic pill, while a tiered drug chart looms behind them.

Therapeutic Substitution: When Your Doctor Doesn’t Get a Say

You might think your doctor picks your medication. Not always.

In 78% of commercial insurance plans, pharmacists are allowed to swap your prescribed generic for another generic - even if your doctor didn’t authorize it. This is called therapeutic substitution. It’s legal. It’s common. And it’s confusing.

A patient prescribed a generic version of lisinopril might get a different generic at the pharmacy. Same active ingredient. Different filler. Sometimes, that changes how the drug works for them. A 2023 Drug Topics survey found 31% of patients reported side effects after a switch they didn’t have with the original drug.

Some states, like Washington, require insurers to notify patients before substitution. Others don’t. That’s why you might get a different pill shape, color, or size - and no warning.

What If Your Generic Isn’t Covered?

If your drug isn’t on the formulary, you’re not out of luck. You can file an exception request.

The process is straightforward: your doctor writes a letter explaining why the covered generic won’t work for you. Maybe you had a bad reaction. Maybe it didn’t control your condition. Maybe you’ve been on the brand name for years and switching caused issues.

Insurers have to respond within three business days. If it’s urgent - like a life-threatening condition - they must respond in one day. If they don’t reply? The request is automatically approved.

The Patient Advocate Foundation found that 78% of patients who appealed a denial eventually got coverage. But here’s the catch: it takes time. And doctors spend an average of 13.3 hours a week just filling out prior authorizations and appeals. That’s time they could be seeing patients.

A doctor writing an appeal letter by candlelight, surrounded by denial letters and one approved notice.

The Bigger Picture: Why This System Exists

From 2007 to 2019, Medicare Part D saved $1.67 trillion by using generics. In 2019 alone, that number was $141 billion. That’s not just good for insurers. It’s good for you.

Without this system, many people couldn’t afford their meds. A brand-name statin might cost $200 a month. The generic? $5. That’s the difference between taking your medicine and skipping it.

But the system isn’t perfect. As Dr. Aaron Kesselheim from Harvard pointed out in JAMA Internal Medicine, focusing too hard on cost can block newer generics that offer real benefits for certain patients. A generic that’s slightly more expensive might have fewer side effects for seniors or people with kidney disease. But if the data isn’t clear, insurers won’t budge.

And now, with the Inflation Reduction Act capping Medicare Part D out-of-pocket costs at $2,000 in 2025, insurers are shifting strategy. Instead of blocking expensive drugs, they’re pushing even harder for high-volume generics. Why? Because they know patients won’t pay more than $2,000 - so they need to control the cost of the drugs that make up the bulk of prescriptions.

What You Can Do

- Ask your pharmacist: “Is there a preferred generic on my plan?” They know the formulary better than you do.

- Check your plan’s formulary: Most insurers have a searchable list online. Look under “Tier 1” for the cheapest options.

- Don’t assume your doctor’s prescription will be covered: Call your insurer before filling it.

- Appeal if needed: If a generic doesn’t work for you, your doctor can fight for coverage. Most appeals succeed.

- Know your rights: In many states, you must be notified if your generic is switched. Ask for a copy of your plan’s substitution policy.

The system isn’t designed to punish you. It’s designed to keep drugs affordable. But it’s not always fair. And it’s not always clear. The more you understand how it works, the less likely you are to get caught off guard.

Why does my insurance cover one generic but not another with the same active ingredient?

Even though two generics have the same active ingredient, insurers choose based on cost, reliability, and real-world performance. One might be cheaper, have fewer supply issues, or have better patient outcomes in studies. The FDA says they’re equivalent, but insurers look at more than just the label.

Can my pharmacist switch my generic without telling me?

In most states, yes - unless your doctor wrote "dispense as written" on the prescription. About 78% of commercial plans allow pharmacists to substitute one generic for another. You might get a different pill color, size, or brand - and not know it until you see the receipt.

What’s the difference between a preferred and non-preferred generic?

Preferred generics are the cheapest and most reliable options on your plan’s formulary. You pay the least for them - often $0 to $15. Non-preferred generics are still covered, but cost more - usually $40 or more. Insurers prefer the cheaper ones to save money and encourage you to use them.

Why are some generics not covered at all?

If a generic isn’t on the formulary, it’s usually because the insurer hasn’t reviewed it, it’s too new, or it’s from a manufacturer with supply problems. Some generics are also excluded if there’s a cheaper, equally effective option already covered. It’s not about quality - it’s about cost and availability.

How do I get a non-covered generic approved?

Your doctor files an exception request with your insurer, explaining why the covered generics won’t work for you - maybe due to side effects, ineffectiveness, or medical history. The insurer must respond within three business days. If they don’t, your request is automatically approved. About 78% of these appeals succeed.

Will the Inflation Reduction Act change how insurers cover generics?

Yes. With the $2,000 annual cap on out-of-pocket drug costs starting in 2025, insurers are shifting focus. Instead of blocking expensive drugs, they’re pushing even harder for high-volume generics. Why? Because they know patients won’t pay more than $2,000 - so they need to control the cost of the drugs that make up the bulk of prescriptions. Expect more generics to be added to Tier 1, and fewer exceptions for brand-name drugs.

Tags: